AH Equity Partners Bio II, L.L.C. — SEC Form 4 filings
SEC reporting owner CIK 1725722. 2 Form 4 filings on record with FilingPulse; latest filed 2026-07-29.
Transaction summary — filings shown
Covers all 2 filings on record, filed 2026-06-04 to 2026-07-29. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 1 leg across 1 filing — 333,333 shares, $4,999,995 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 5,000,000 shares, $11,750,000 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 4.
- Largest priced transaction: sale of 4,615,974 shares @ $2.35 ($10,847,539) in Nautilus Biotechnology, Inc., filed 2026-06-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Nautilus Biotechnology, Inc. (NAUT) | 10% owner | 1 | — | 2 legs · 5,000,000 sh · $11,750,000 | — |
| Scribe Therapeutics, Inc. (SCTX) | 10% owner | 1 | 1 leg · 333,333 sh · $4,999,995 | — | 4 |
Form 4 filings — AH Equity Partners Bio II, L.L.C.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-29 | 4 | Scribe Therapeutics, Inc. (SCTX) jointly with AH Bio Fund II, L.P., AH Bio Fund III, L.P., AH Equity Partners Bio III, L.L.C., Andreessen Marc L, HOROWITZ BENJAMIN A | Conversion (C): 2,051,742 · Conversion (C): 697,650 · Purchase (P): 333,333 @ $15 · Conversion (C): 12,150,003 (derivative) @ $0 · Conversion (C): 4,131,344 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Nautilus Biotechnology, Inc. (NAUT) jointly with Andreessen Horowitz LSV Fund II, L.P., AH Bio Fund II, L.P., AH Equity Partners LSV II, L.L.C., Andreessen Marc L, HOROWITZ BENJAMIN A | Sale (S): 4,615,974 @ $2.35 · Sale (S): 384,026 @ $2.35 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1725722 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →